Article detail · 2023
Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study
Journal
Lancet Infect DisISSN 1473-3099
The ISSN points to another catalog journal; the name is from the YÖKSİS record.
YÖKSİS
OpenAlex
Open access · bronze
SJR Q1
JCR Q1
Citations 151
Top 1%
Percentile 99.8%
FWCI 24.82
- Year
- 2023
- Type
- article
Data source split
- YÖKSİS YÖKSİS article record
- YÖKSİS venue Lancet Infect Dis
- Catalog match (ISSN) The Lancet Infectious Diseases
- OpenAlex OpenAlex enrichment (abstract, citations, topics)
Abstract
Abstract not compiled yet; it will appear after the DergiPark / OpenAlex queue runs.
Topics
Citations
OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.
151 citations
OpenAlex cited_by_count (cache / database)
20 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).
- Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM 2025
- Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM 2025
- Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap 2023
- Attributable mortality of candidemia – Results from the ECMM Candida III multinational European Observational Cohort Study 2024
- Attributable mortality of candidemia – Results from the ECMM Candida III multinational European Observational Cohort Study 2024
- Attributable mortality of candidemia - Results from the ECMM Candida III multinational European Observational Cohort Study. 2024
- European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: Results from the ECMM Candida III study 2023
- Attributable mortality of candidemia – Results from the ECMM Candida III multinational European Observational Cohort Study 2024
- European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: Results from the ECMM Candida III study 2023
- European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: Results from the ECMM Candida III study 2023